Skip Navigation

SELVAS Healthcare Launches AI-based Body Composition Analyzer ‘ACCUNIQ BC380’ Worldwide

Intelligent body composition analyzer based on latest information technology and US clinical test results
Industry’s first after-sales remote support program to enable remote tech support anywhere in the world

News provided by SELVAS Healthcare
02 Oct 2017, 17:00 KST
  • SELVAS Healthcare's AI-based Body Composition Analyzer ACCUNIQ BC380

SEOUL--(Korea Newswire) 02 October, 2017 -- SELVAS Healthcare has launched a next generation body composition analyzer ACCUNIQ BC380.

ACCUNIQ BC380 is a next-generation intelligent body composition analyzer, which reflects the digital healthcare company’s accumulated product development know-how, cutting-edge information technology and the findings of consumer researches conducted in step with market trends and US clinical test results.

The new analyzer has further raised the accuracy of body composition measurement through its high correlation with Dual Energy X-ray Absorptiometry (DEXA) at a US clinical trial center IHT. It also applied innovative software technologies to product design, UI screens and result sheets.

The industry’s first after-sales service ‘ACCUNIQ Remote Support’ connects users to the customer service department of SELVAS Healthcare remotely from anywhere around the world. As a result, ACCUNIQ BC380 can be diagnosed, repaired and upgraded more easily.

The new product also offers personalized diet and exercise prescriptions personalized on the basis of measurement data in conjunction with ACCUNIQ Manager, proprietary software to manage individual user’s body composition data. It can be linked with a series of ACCUNIQ ultrasound height meter and fully automatic blood pressure monitors.

“By launching ACCUNIQ BC380, we plan to set a new industry standard for body composition analyzers in the global market,” SELVAS Healthcare CEO Ken B. Yoo said, “Our goal is to become a leading digital healthcare company by integrating our expertise in body composition analysis, artificial intelligence and IoT technologies.”

ACCUNIQ BC380 will be exhibited at the MEDICA 2017 (Booth No.11F67), in Dusseldorf, Germany from November 13~16.

SELVAS Healthcare, Inc. was listed on KOSDAQ in September 2016 after it was renamed from Jawon Medical Co., a leading medical device manufacturer since 1993. SELVAS Healthcare has been solidifying its position in the global medical device market by releasing innovative products based on the AI technology of its subsidiary SELVAS AI. Its major products include ACCUNIQ BP850 (a.k.a. EX PLUS 1300), world’s first dual-arm blood pressure monitor which can measure the blood pressures difference between both arms, body composition analyzers, braille terminals, video magnifiers and text-to-speech voice readers.

Contact

SELVAS Group
Kate Kim
+82-2-6190-7676
kate.e.kim@selvas.com

This is a news release distributed by Korea Newswire on behalf of this company . Learn more

Share this News Release

Distribute Your News to South Korea

Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
  • 28,000journalists
  • 4,000media outlets
  • 230industry fields
  • 55,000subscribers
Learn more